Role of recombinant human erythropoietin in patients of advanced cervical cancer treated by chemoradiotherapy

Abstract

Treatment with epoetin beta safely and effectively corrects anemia in patients with advanced cervical cancer receiving chemoradiotherapy and is not associated with adverse effects on response rate, overall survival, disease free survival and chemoradiotherapy related acute and late toxicities.